Q4 2023 TRACON Pharmaceuticals Inc Earnings Call Transcript
Good day, ladies and gentlemen, and welcome to the Trikon Pharmaceuticals Fourth Quarter and Year End 2023 earnings conference call. At this time, all callers are in a listen-only mode. After the speakers' prepared remarks, we will conduct a question and answer session and instructions will be given.
During today's call, we will be making certain forward-looking statements, including statements regarding expected timing of clinical trials and results, good trade activities, financing financing opportunities are development, plan and strategies, central cost savings and other benefits deliverable through development platform or PDP. ability to enter into additional license agreements and expectations regarding and so in the full Bonava treatments continuing to generate a double digit, the response rate, can you statements are subject to change and are described in our filings made with the Securities and Exchange Commission, including our annual and Form 10 K for the year ended December 31st, 2023 and such REPORT and Forms 10 Q. You are cautioned not to place undue reliance on these forward-looking
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |